chr6-155257961-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000367166.5(TFB1M):c.916G>A(p.Val306Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000712 in 1,614,204 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000367166.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TFB1M | NM_016020.4 | c.916G>A | p.Val306Ile | missense_variant | 7/7 | ENST00000367166.5 | NP_057104.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TFB1M | ENST00000367166.5 | c.916G>A | p.Val306Ile | missense_variant | 7/7 | 1 | NM_016020.4 | ENSP00000356134 | P1 | |
TFB1M | ENST00000468889.5 | n.366-53G>A | intron_variant, non_coding_transcript_variant | 3 | ||||||
TFB1M | ENST00000470239.1 | n.198-53G>A | intron_variant, non_coding_transcript_variant | 3 | ||||||
TFB1M | ENST00000495806.1 | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000155 AC: 39AN: 251008Hom.: 1 AF XY: 0.000199 AC XY: 27AN XY: 135746
GnomAD4 exome AF: 0.0000759 AC: 111AN: 1461892Hom.: 1 Cov.: 31 AF XY: 0.000116 AC XY: 84AN XY: 727246
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152312Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2023 | The c.916G>A (p.V306I) alteration is located in exon 7 (coding exon 7) of the TFB1M gene. This alteration results from a G to A substitution at nucleotide position 916, causing the valine (V) at amino acid position 306 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at